Hepatocellular carcinoma (HCC) is the fourth leading cause of cancer-related mortality worldwide. Much recent research has delved into understanding the underlying molecular …
Current immunotherapies provide limited benefits against T cell-depleted tumors, calling for therapeutic innovation. Using multi-omics integration of cancer patient data, we predict a …
EE Mohammed, N Türkel, UM Yigit, AB Dalan… - … Trace Element Research, 2023 - Springer
Breast cancer is the most frequently diagnosed cancer among women worldwide. Despite the initial clinical response obtained with the widely used conventional chemotherapy, an …
L Pu, Y Sun, C Pu, X Zhang, D Wang, X Liu, P Guo… - Scientific Reports, 2024 - nature.com
Disulfidptosis a new cell death mode, which can cause the death of Hepatocellular Carcinoma (HCC) cells. However, the significance of disulfidptosis-related Long non-coding …
Q Zhang, G Dong, F Wang, W Ding - Journal of Cancer Research …, 2020 - journals.lww.com
Aims: The aim of this study is to investigate the correlation between changes in serum cyclooxygenase-2 (COX-2), basic fibroblast growth factor (bFGF), vascular endothelial …
Z Dai, X Peng, X Cui, Y Guo, J Zhang, X Shen… - Journal of Cancer …, 2023 - Springer
Purpose Colon cancer is highly heterogeneous in terms of the immune and stromal microenvironment, genomic integrity, and oncogenic properties; therefore, molecular …
N Ding, X Fan, H Guo, D Xue… - American Journal of …, 2024 - pmc.ncbi.nlm.nih.gov
Objective: To assess the predictive value of serum alkaline phosphatase (ALP), tumor- specific growth factor (TSGF), and macrophage migration inhibitory factor (MIF) for the …
J Zhu, W Zhao, J Yang, C Liu, Y Wang… - Anti-Cancer …, 2024 - journals.lww.com
Anoikis is a programmed cell death process triggered when cells are dislodged from the extracellular matrix. Numerous long noncoding RNAs (lncRNAs) have been identified as …
X Jin, X Liu, Z Zhou, Y Ding, Y Wu, J Qiu… - Cancer Immunology …, 2022 - Springer
Hepatocellular carcinoma (HCC) is a malignant tumor with high mortality, but lacks effective treatments. Carcinoembryonic antigen glypican-3 (GPC3) is a tumor-associated antigen …